
Soliton, Inc. Market Cap 2011-2026 | SOLY
As of March 24, 2026 Soliton, Inc. has a market cap of $ 435 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Soliton, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 229 M | 170 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 229 M | 170 M | 199 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Inogen
INGN
|
160 M | $ 6.32 | -2.02 % | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
1.25 B | $ 99.89 | 0.69 % | $ 1.27 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.35 | -0.04 % | $ 21.8 M | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
LivaNova PLC
LIVN
|
3.81 B | $ 63.27 | 0.05 % | $ 3.45 B | ||
|
LENSAR
LNSR
|
130 M | $ 5.71 | -5.93 % | $ 65.8 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 32.42 | 2.11 % | $ 1.49 B | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 36.72 | 0.25 % | $ 1.14 B | ||
|
Medtronic PLC
MDT
|
111 B | $ 86.65 | -0.64 % | $ 111 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
175 M | $ 24.67 | 0.73 % | $ 209 M | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.72 | 6.7 % | $ 39.2 M | ||
|
Aethlon Medical
AEMD
|
3.03 M | $ 2.15 | -6.52 % | $ 3.36 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
491 M | $ 11.77 | -0.84 % | $ 466 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.48 | 10.66 % | $ 1.55 B | ||
|
Myomo
MYO
|
33.9 M | $ 0.69 | -2.17 % | $ 28.9 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.33 | -4.71 % | $ 137 M | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 3.85 | 3.08 % | $ 144 M | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.84 | -3.83 % | $ 372 M | ||
|
Penumbra
PEN
|
13.2 B | $ 334.58 | -0.3 % | $ 13 B | ||
|
Outset Medical
OM
|
52.5 K | $ 3.49 | -3.6 % | $ 53.1 K | ||
|
Inspire Medical Systems
INSP
|
1.76 B | $ 51.53 | -1.3 % | $ 1.51 B | ||
|
Insulet Corporation
PODD
|
18.1 B | $ 225.21 | -0.82 % | $ 15.8 B | ||
|
Profound Medical Corp.
PROF
|
230 M | $ 5.1 | -5.56 % | $ 180 M | ||
|
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.33 | -4.68 % | $ 54.1 M | ||
|
Quanterix Corporation
QTRX
|
269 M | $ 3.68 | -6.73 % | $ 157 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
InspireMD
NSPR
|
115 M | $ 1.8 | 4.05 % | $ 116 M | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M |